Search Results for: Zolgensma

Zolgensma (AVXS-101)

Zolgensma, previously knowns as AVXS-101, is the proprietary gene therapy candidate from AveXis designed to treat spinal muscular atrophy (SMA). How Zolgensma works SMA is caused by a mutation in the ... Read more